A jail mailroom, an ambulance crew, and a county harm reduction program all face the same object: an envelope, a pill, a baggie, or a piece of foil with a residue nobody can identify. The buyer's job is to put a fast, defensible presumptive test in their hands and to keep that test from being mistaken for a lab result or a medical diagnosis. Most procurement mistakes here come from buying the wrong test type, misreading the label, or writing a policy that treats a five minute strip as proof.
Residue tests are not drug tests for people
A residue test swabs an object. A urine or oral fluid test samples a person. They answer different questions, carry different labels, and cannot substitute for each other.
Healgen describes its fentanyl and xylazine residue line as a rapid screening test for the qualitative detection of fentanyl or xylazine residue, such as dried liquid or powder, on surfaces, including the outer surface of pills. The strip reads in 3 to 10 minutes and the cassette in 5 to 10 minutes, and the manufacturer says not to interpret results after one hour. Cutoffs are 5 ng/mL for fentanyl and 50 ng/mL for xylazine.
| Question | Residue test | Urine or oral fluid test |
|---|---|---|
| What is sampled | Swab of mail, packaging, pill exterior, paraphernalia | Specimen from a person |
| What a positive means | Drug residue was on the object at or above cutoff | Drug or metabolite was in the specimen at or above cutoff |
| Label | For Forensic Use Only | CLIA waived, 510(k) cleared, or OTC |
| Keystone examples | Healgen GBFEN-1001a fentanyl-only strip, GBXYL-1001a xylazine-only strip, GBDOA-1025-001 fentanyl and xylazine combo cassette | Healgen GBFEN-101g fentanyl strip, GBFEN-102g cassette, GBFEN-105g dip, all CLIA waived at 1 ng/mL |
Buy the urine line for anything that touches patient care or a treatment plan. Buy the residue line for objects.
What For Forensic Use Only means
The label is a regulatory boundary, not a quality grade. In a briefing to SAMHSA's Drug Testing Advisory Board, FDA staff stated that the agency does not actively regulate, through enforcement discretion, devices labeled to be used only by law enforcement. The same briefing notes that most drugs of abuse tests intended for medical use are Class II devices that require 510(k) clearance before marketing.
For a buyer, that means three things:
- A forensic-only kit has not been reviewed by FDA for diagnosing or treating a person. Do not run it on urine and do not put its result in a chart.
- Its performance data comes from the manufacturer, not from an FDA decision summary. Ask for the insert and the cutoff before you standardize.
- Your written policy must call the result presumptive and say what happens next.
Why xylazine tests exist at all
On April 12, 2023, the Director of the White House Office of National Drug Control Policy designated fentanyl adulterated or associated with xylazine as an emerging drug threat, the first use of that authority under the SUPPORT Act. Xylazine is a veterinary sedative approved for animal use in 1972 and known on the street as tranq. By March 2023 it had been detected in drug seizures in 48 states. Naloxone reverses opioid respiratory depression but does not reverse xylazine, and no xylazine reversal agent is approved for humans.
The response plan named a gap buyers still feel: rapid point-of-care testing for xylazine was not widely available, and the plan called for rapid development and distribution of reliable point-of-care tests for both biologic specimens and drug products. Xylazine-only strips and fentanyl and xylazine combination cassettes are the product answer to that gap.
How mailrooms, EMS, and programs actually use them
Jail and prison mailrooms. Staff swab suspect paper, envelopes, and card stock, then run the strip. A positive triggers segregation of the item, a photograph of the strip inside the read window, a log entry, and a laboratory request. The 2024 New York City Department of Investigation review of Rikers Island mail shows why the lab step is not optional. Investigators retested 71 pieces of mail that field tests had flagged for fentanyl. Ten contained the drug. The overall false positive rate was 85 percent, and the two kit brands in use ran 79 and 91 percent. Federal rules require manufacturers to state on packaging that results are preliminary until confirmed by a lab, a step the report found rarely happened in that setting.
EMS and law enforcement. Crews use residue tests to document what was on a pill bottle, foil, or counter at a scene for the run report. Treatment decisions are clinical and do not wait for a strip, and a negative strip does not rule out an opioid.
Community and public health programs. Drug checking programs use fentanyl and xylazine strips so a person can learn what is in a substance before use. New York State's guidance is direct about the limits: strips cannot determine the quantity, purity, or type of fentanyl in a substance, and a negative does not mean a substance is safe.
Cross-reactivity and the lab standard
Strips are immunoassays. High concentrations of other compounds can bind the antibody and produce a false positive. New York's guidance lists methamphetamine, MDMA, and diphenhydramine as the common offenders and gives a fix: dilute methamphetamine or MDMA samples at one teaspoon of water per 10 mg of powder, and all other substances at half a teaspoon per 10 mg. The same guidance puts the false negative rate for fentanyl strips at 3.7 percent.
FDA's briefing to SAMHSA identifies the gold standard comparator for drug test accuracy as GC/MS or LC-MS/MS. Any result that drives discipline, a criminal referral, denial of mail, or a public alert goes to a laboratory for mass spectrometry confirmation. Document each test the same way:
- Date, time, location, and the person who ran the test.
- Item description and identifier from your evidence or mail log.
- Kit manufacturer, SKU, and expiration date.
- Photo of the strip or cassette taken inside the manufacturer's read window.
- Disposition: held, released, or sent to the lab, with the lab request number.
Funding rules and how to stock this category this week
Grant language changed this year. SAMHSA's April 24, 2026 letter states that it is against administration policy to publicly distribute test strips used to detect fentanyl, xylazine, and medetomidine to the public. The same letter keeps federal funds available for strips used by public health officials, law enforcement, medical workers, and others who use them in professional settings. Agencies buying residue tests for staff use sit inside that carve-out. A program that hands strips to the public needs a non-federal line item for that portion of the order. Keep the two uses on separate purchase orders so the audit trail is clean.
Send the sales department your mail volume, the number of stations, and whether you need fentanyl-only, xylazine-only, or combination formats. In-stock Healgen residue tests ship from Edina, Minnesota in 1 to 3 business days, quotes go out the same business day, and approved accounts get Net 30. If a format goes on backorder, Keystone offers a verified equivalent with the same sample type and cutoff shown on the quote. Browse harm reduction and public health supplies for residue tests and drug checking supplies, or contact the sales department with your list.
Sources
- https://bidenwhitehouse.archives.gov/ondcp/briefing-room/2023/04/26/nejm-publishes-ondcp-op-ed-on-the-medical-and-public-health-imperatives-surrounding-xylazine-which-dr-gupta-designated-as-an-emerging-drug-threat-to-the-nation/
- https://healgen.com/human-health/toxicology/fentanyl-xylazine-residue-test/
- https://www.samhsa.gov/sites/default/files/meeting/documents/dtab-fda-regulation-drugs-abuse-tests-clearance.pdf
- https://www.nbcnewyork.com/manhattan/faulty-fentanyl-tests-spurred-nycs-push-to-ban-mail-on-rikers-island/6003949/
- https://oasas.ny.gov/system/files/documents/2023/03/fentanyl_test_strip_guidance_0.pdf
- https://www.statnews.com/2026/04/27/trump-administration-samhsa-clear-shift-from-harm-reduction/

